Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02721576
What this trial is testing

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

Who this might be right for
Esophageal Neoplasms
Shandong Cancer Hospital and Institute 8
Not applicableUnknownNCT05426850
What this trial is testing

CtDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 100
Early research (Phase 1)Study completedNCT01822613
What this trial is testing

Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Novartis Pharmaceuticals 48
Not applicableNot Yet RecruitingNCT07067450
What this trial is testing

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Sichuan University 98
Large-scale testing (Phase 3)UnknownNCT01402180
What this trial is testing

Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Testing effectiveness (Phase 2)UnknownNCT05394415
What this trial is testing

Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaTislelizumabChemoradiation
Jiangsu Cancer Institute & Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493993
What this trial is testing

Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 26
Large-scale testing (Phase 3)Study completedNCT02399306
What this trial is testing

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEnteral Nutrition TherapyChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 222
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814158
What this trial is testing

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Who this might be right for
Esophageal Squamour Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 57
Not applicableUnknownNCT06478355
What this trial is testing

Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）

Who this might be right for
ESCC
Hebei Medical University Fourth Hospital 800
Testing effectiveness (Phase 2)Study completedNCT00520091
What this trial is testing

Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer

Who this might be right for
Esophageal Cancer
UNC Lineberger Comprehensive Cancer Center 14
Large-scale testing (Phase 3)Not Yet RecruitingNCT06501664
What this trial is testing

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Who this might be right for
Esophageal Cancer
Rui-hua Xu, MD, PhD 360
Large-scale testing (Phase 3)Looking for participantsNCT05495152
What this trial is testing

Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 219
Not applicableStudy completedNCT06190652
What this trial is testing

Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 728
Early research (Phase 1)Study completedNCT03792347
What this trial is testing

Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hecheng Li M.D., Ph.D 20
Not applicableLooking for participantsNCT07627347
What this trial is testing

Efficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC)

Who this might be right for
ESCC
Nanfang Hospital, Southern Medical University 25
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Next Page